Navigation Links
HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
Date:11/9/2009

SAN DIEGO, Nov. 9 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is another in a series of collaborations that HUYA has established with China's leading research and development institutions to enable and accelerate the global development and commercialization of novel biopharmaceutical product opportunities originating in China.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new pre-clinical and clinical stage compounds. The agreement with Ocean University of China provides HUYA with rights of first review and negotiation relating to certain novel therapeutic and diagnostic product candidates owned or controlled by the University. In return, Ocean University of China gains access to HUYA's global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.

"Ocean University is one of China's leading institutions, with considerable expertise in the field of marine pharmaceutical science," said Michael Newman, Ph.D., Executive Vice President of Oncology at HUYA Bioscience. "We look forward to collaborating with this prestigious university to bring novel biopharmaceutical products to the global marketplace."

"Ocean University is committed to strengthening its research programs in marine pharmaceutical science," said Qiangming Wu, Ph.D., Executive Dean, School of Medicine and Pharmacy, Ocean University of China. "We are pleased to partner with HUYA's expert team to achieve this objective."

ABOUT HUYA

HUYA is the leader in global pharmaceutical co-development with China. With six strategic offices in China, the broadest Chinese compound portfolio, and more exclusive agreements with premier Chinese biotech centers than any other company, HUYA has pioneered the most innovative and productive approach to pharmaceutical co-development between the U.S. and China. HUYA has joint headquarter offices in San Diego, CA, and Shanghai. Additional information about the company is available at www.huyabio.com.

ABOUT OCEAN UNIVERSITY OF CHINA

Ocean University of China, located in Qingdao, is one of the top universities in China. It is considered a leader in research in the area of marine pharmaceutical science, and has received numerous awards for its work. The University has undertaken a large number of research papers and made great contributions to the construction of the marine-based economy of Shandong Province, including projects such as the seawater aquaculture. Ocean University has been ranked No. 8 in terms of the number of prizes won for science and technology advancement awarded by the Ministry of Education. For more information visit www.ouc.edu.cn/english.

    CONTACT:

    USA:
    Bob Giargiari, MBA, EVP Finance & CFO
    HUYA Bioscience International, LLC
    (858) 798-8800
    bgiargiari@huyabio.com

    China:
    Qing (Vicky) Xia, Scientific Research Manager
    HUYA Bioscience International, LLC
    86 (21) 51323312
    vxia@huyabio.com

    Media Contact:
    Juliet Travis
    (510) 452-3771
    juliet@travispr.com

SOURCE HUYA Bioscience International


'/>"/>
SOURCE HUYA Bioscience International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Professionals in bioscience, food-related industries turn to K-State
4. Aeon Bioscience Continues Development of Drug Eluting Stents
5. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
6. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
7. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
8. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
9. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
10. Anaptys Biosciences Raises Over $33 Million in Series B Financing
11. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Wausau, WI (PRWEB) , ... February 27, 2017 , ... ... Young Investigator Award. Dr. Chen will receive his award during the Plenary Session at ... Inc. (ASLMS), to be held in San Diego, California April 5-9, 2017. , ...
(Date:2/27/2017)... ... 27, 2017 , ... Robert E. Burke, MD, PhD, had a successful career ... and life experiences could have led him down a much different path. , In ... Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of the tribulations he ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare ... for a company involved in the underground testing of nuclear weapons. Years later, when ... Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made ...
(Date:2/27/2017)... ... 27, 2017 , ... This webinar , sponsored by ... tool to characterize particle size distributions in the field of geoscience and soil ... scientific findings. It describes methods of optimized and standardized sample collection, preparation and ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... March 2014. The company had 800 customers and 2,250 RCEs at the time ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... The global  pulse oximeters market  is expected to reach USD 2.8 ... The pulse oximeters market is anticipated to witness significant growth during the forecast ... as chronic obstructive pulmonary disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. ... ... Grand View Research Logo ...
(Date:2/28/2017)... This report provides all the information you require to ... since 2010. Download the full report: ... Alliance since 2010 report provides an in-depth insight into ... life sciences companies. On demand company reports ... most up to date deal and company data. ...
(Date:2/28/2017)... , Feb 28, 2017 ... Research and Markets ... 2025" report to their offering. The global ... The orthobiologics market is predominantly driven by ... technological innovations in biomaterials, used in the production of orthobiologics are ...
Breaking Medicine Technology: